2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Manufacturing for Personalized Medicine: Customised Cell Products at Scale

The manufacturing of personalized medicine occupies an imperative place in the spectrum of innovation and scale associated with the development of new adaptive cell and gene therapies. Increase of more personalized and bespoke treatments, to manufacture custom, individualized cell products in a way that is consistent, high-quality, regulatory-compliant, and can be scaled up and out to commercial levels.

The Cell and gene therapy meeting will provide a unique insight into these considerations and how they relate to next-generation technologies, process innovations, and consider ongoing and future manufacturing visionary practices - ensuring that bespoke, individually manufactured high-quality cell therapies.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis